Dr. Stefan Medina Bravo, MD

NPI: 1023545944
Total Payments
$750.66
2023 Payments
$47.91
Companies
7
Transactions
11

Payment Breakdown by Category

Food & Beverage$750.66 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $750.66 11 100.0%

Top Paying Companies

Company Total Records Latest Year
Amgen Inc. $244.13 2 $0 (2018)
Merck Sharp & Dohme Corporation $167.56 2 $0 (2019)
E.R. Squibb & Sons, L.L.C. $147.74 2 $0 (2018)
Gilead Sciences, Inc. $131.87 2 $0 (2018)
ABBVIE INC. $28.45 1 $0 (2023)
Janssen Pharmaceuticals, Inc $19.46 1 $0 (2023)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $11.45 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2023 $47.91 2 ABBVIE INC. ($28.45)
2019 $167.56 2 Merck Sharp & Dohme Corporation ($167.56)
2018 $469.91 6 Amgen Inc. ($244.13)
2017 $65.28 1 E.R. Squibb & Sons, L.L.C. ($65.28)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/25/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $19.46 General
Category: Cardiovascular & Metabolism
08/20/2023 ABBVIE INC. Food and Beverage In-kind items and services $28.45 General
05/21/2019 Merck Sharp & Dohme Corporation BRIDION (Drug) Food and Beverage In-kind items and services $67.57 General
Category: NEUROSCIENCE
03/05/2019 Merck Sharp & Dohme Corporation BRIDION (Drug) Food and Beverage In-kind items and services $99.99 General
Category: NEUROSCIENCE
05/31/2018 Amgen Inc. Enbrel (Biological) Food and Beverage In-kind items and services $122.07 General
Category: Inflammation
05/16/2018 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $82.46 General
Category: Cardiovascular
05/10/2018 Gilead Sciences, Inc. Epclusa (Drug) Food and Beverage In-kind items and services $103.72 General
Category: HCV
03/20/2018 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $122.06 General
Category: Cardiology
02/16/2018 Gilead Sciences, Inc. Epclusa (Drug) Food and Beverage In-kind items and services $28.15 General
Category: HCV
01/09/2018 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $11.45 General
Category: Electromedical and Electrotherapeutic Apparatus
10/25/2017 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $65.28 General
Category: Cardiovascular

About Dr. Stefan Medina Bravo, MD

Dr. Stefan Medina Bravo, MD is a Anesthesiology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2017. The National Provider Identifier (NPI) number assigned to this provider is 1023545944.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stefan Medina Bravo, MD has received a total of $750.66 in payments from pharmaceutical and medical device companies, with $47.91 received in 2023. These payments were reported across 11 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($750.66).

Practice Information

  • Specialty Anesthesiology
  • Other Specialties Internal Medicine, Anesthesiology
  • Location Brooklyn, NY
  • Active Since 05/23/2017
  • Last Updated 03/05/2021
  • Taxonomy Code 207L00000X
  • Entity Type Individual
  • NPI Number 1023545944

Products in Payments

  • BRIDION (Drug) $167.56
  • ELIQUIS (Drug) $147.74
  • Epclusa (Drug) $131.87
  • Enbrel (Biological) $122.07
  • Repatha (Biological) $122.06
  • XARELTO (Drug) $19.46
  • LifeVest (Device) $11.45

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anesthesiology Doctors in Brooklyn